Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Neuphoria Therapeutics (NEUP) over the last 6 years, with Q4 2025 value amounting to -$69586.0.

  • Neuphoria Therapeutics' Non-Current Deferred Tax Liability rose 4230.93% to -$69586.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$69586.0, marking a year-over-year increase of 4230.93%. This contributed to the annual value of $495113.0 for FY2025, which is N/A changed from last year.
  • As of Q4 2025, Neuphoria Therapeutics' Non-Current Deferred Tax Liability stood at -$69586.0, which was up 4230.93% from $460320.0 recorded in Q3 2025.
  • Neuphoria Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $1.3 million during Q4 2021, with a 5-year trough of -$120619.0 in Q4 2024.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $761737.0 (2025), whereas its average is $674082.8.
  • Examining YoY changes over the last 5 years, Neuphoria Therapeutics' Non-Current Deferred Tax Liability showed a top increase of 4230.93% in 2025 and a maximum decrease of 4462.81% in 2025.
  • Neuphoria Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $1.3 million in 2021, then dropped by 1.94% to $1.3 million in 2022, then decreased by 14.12% to $1.1 million in 2023, then plummeted by 110.9% to -$120619.0 in 2024, then surged by 42.31% to -$69586.0 in 2025.
  • Its Non-Current Deferred Tax Liability was -$69586.0 in Q4 2025, compared to $460320.0 in Q3 2025 and $495113.0 in Q2 2025.